[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369761-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369761-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","vitamin-d-gut-microbiota-and-cancer-immunotherapy-a-potentially-effective-crosstalk","Vitamin D, Gut Microbiota, and Cancer Immunotherapy - A Potentially Effective Crosstalk","","Recent breakthroughs in cancer immunotherapy show strong overall promise, yet individual treatment efficacy varies widely. Gut microbiota has emerged as a major determinant of immunotherapy responsiveness, while vitamin D (VD) is an immunomodulatory hormone possibly affecting both microbiota and outcomes. The review systematically synthesizes peer-reviewed evidence from multiple databases to clarify VD–microbiota–immunity interactions and their clinical implications.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/vitamin-d-gut-microbiota-and-cancer-immunotherapy-a-potentially-effective-crosstalk/369761/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/vitamin-d-gut-microbiota-and-cancer-immunotherapy-a-potentially-effective-crosstalk/369761.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of this review?","Question",{"text":63,"@type":64},"It examines how vitamin D interacts with the gut microbiota and cancer immunotherapy, highlighting synergistic and context-dependent effects and underlying mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How might vitamin D influence cancer immunotherapy response?",{"text":68,"@type":64},"Vitamin D can modulate immune cells via vitamin D receptor (VDR) signaling and can also reshape gut microbial composition to support antitumor immunity.",{"name":70,"@type":61,"acceptedAnswer":71},"Why do clinical results on vitamin D show paradoxical patterns?",{"text":72,"@type":64},"Evidence indicates that optimal vitamin D levels may improve immunotherapy responses and reduce toxicity in some studies, while other studies link deficiency or excess to immunosuppression and poorer survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369761,1791152492,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":103,"preview_page_count":33,"preview_urls":144},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Review  \nVitamin D, Gut Microbiota, and Cancer Immunotherapy—A Potentially Effective Crosstalk  \nYizhen Yan 1,2,†, Yi Guo 2,†, Yiting Li 2, Qingrui Jiang 2, Chenhang Yuan 2, Li Zhao 1 and Shanshan Mao 1,2, *  \nAcademic Editor: Geoffrey Brown  \nReceived: 1 June 2025  \nRevised: 11 July 2025  \nAccepted: 18 July 2025  \nPublished: 22 July 2025  \nCitation: Yan, Y.; Guo, Y.; Li, Y.; Jiang, Q.; Yuan, C.; Zhao, L.; Mao, S. Vitamin D, Gut Microbiota, and Cancer Immunotherapy—A Potentially Effective Crosstalk. Int. J. Mol. Sci. 2025, 26, 7052. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms26157052](10.3390/ijms26157052)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Beijing Key Laboratory of Sports Performance and Skill Assessment, Beijing Sport University, Beijing 100084, China; [yanyiz@126.com](yanyiz@126.com) (Y.Y.)  \n2 School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing 100084, China; [yi___guo@163.com](yi___guo@163.com) (Y.G.)  \n* Correspondence: [ss.mao@bsu.edu.cn](ss.mao@bsu.edu.cn)  \n† These two authors contributed equally to this work.  \nAbstract  \nRecent breakthroughs in cancer immunotherapy have shown remarkable success, yet treatment efficacy varies significantly among individuals. Emerging evidence highlights the gut microbiota as a key modulator of immunotherapy response, while vitamin D (VD), an immunomodulatory hormone, has garnered increasing attention for its potential interactions with gut microbiota and immunotherapy outcomes. However, the precise mechanisms and clinical applications of VD in this context remain controversial. This study systematically analyzed peer-reviewed evidence from PubMed, Scopus, Web of Science, PsycINFO, and MEDLINE (January 2000–May 2025) to investigate the complex interplay among VD, gut microbiota, and cancer immunotherapy. This review demonstrates that VD exerts dual immunomodulatory effects by directly activating immune cells through vitamin D receptor (VDR) signaling while simultaneously reshaping gut microbial composition to enhance antitumor immunity. Clinical data reveal paradoxical outcomes: optimal VD levels correlate with improved immunotherapy responses and reduced toxicity in some studies yet are associated with immunosuppression and poorer survival in others. The bidirectional VD–microbiota interaction further complicates this relationship: VD supplementation enriches beneficial bacteria, which reciprocally regulate VD metabolism and amplify immune responses, whereas excessive VD intake may disrupt this balance, leading to dysbiosis and compromised therapeutic efficacy. These findings underscore the need to elucidate VD’s dose-dependent and microbiota-mediated mechanisms to optimize its clinical application in immunotherapy regimens. Future research should prioritize mechanistic studies of VD’s immunoregulatory pathways, personalized strategies accounting for host–microbiota variability, and large-scale clinical trials to validate VD’s role as anadjuvant in precision immunotherapy.  \nKeywords: vitamin D; gut microbiota; cancer immunotherapy; crosstalk  \n1. Introduction  \nCancer immunotherapy has revolutionized oncology by harnessing the immune system to target and eliminate malignant cells. Despite its transformative potential, the efficacy of immunotherapy varies widely among patients, with many experiencing limited responses or significant adverse effects. This variability underscores the need to identify factors that can optimize treatment outcomes [1,2] .  \nAmong these, vitamin D (VD) and the gut microbiota have emerged as critical modulators of immune function, with growing evidence suggesting their interplay may influence immunoth","cbCaiv4VD2TT9rNY","https://ap.wps.com/l/cbCaiv4VD2TT9rNY","pdf",1881363,"English","# Abstract\n# 1. Introduction\n# 2. Methods\n## 2.1. Search Strategy","[{\"question\":\"What is the main focus of this review?\",\"answer\":\"It examines how vitamin D interacts with the gut microbiota and cancer immunotherapy, highlighting synergistic and context-dependent effects and underlying mechanisms.\"},{\"question\":\"How might vitamin D influence cancer immunotherapy response?\",\"answer\":\"Vitamin D can modulate immune cells via vitamin D receptor (VDR) signaling and can also reshape gut microbial composition to support antitumor immunity.\"},{\"question\":\"Why do clinical results on vitamin D show paradoxical patterns?\",\"answer\":\"Evidence indicates that optimal vitamin D levels may improve immunotherapy responses and reduce toxicity in some studies, while other studies link deficiency or excess to immunosuppression and poorer survival.\"}]","Vitamin D, Gut Microbiota, and Cancer Immunotherapy - A Potentially Effective Crosstalk | PDF",1790184393,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bb455500bf1a435edc459b66e788c7f.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5e8d82771f25dd21c0ac9da919ba445.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf91a7b60f897a935a2b85be3bf730cf.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1a5a0bc4723cb9bf6917da318d89fe7.webp",980,1385]